[PDF][PDF] Balloon angioplasty for intracranial atherosclerotic disease
… were discharged on antiplatelet therapy unless warfarin was … Dual antiplatelet agents with
aspirin and clopidogrel, as … the postprocedure neurological assessment may not have been …
aspirin and clopidogrel, as … the postprocedure neurological assessment may not have been …
经皮冠状动脉介入术后心房颤动患者双联抗栓与三联抗栓治疗效果的Meta 分析
樊春蕾 - 2018 - ir.lzu.edu.cn
… :To systemically evaluate the efficacy and safety of warfarin … study showed that triple
antithrombotic therapy for patients with … was not lower in patients with dual antithrombotic than …
antithrombotic therapy for patients with … was not lower in patients with dual antithrombotic than …
冠心病合并心房颤动患者PCI 术后两联与三联抗栓治疗安全性和有效性的meta 分析
赵丹， 周鹏 - 临床心血管病杂志, 2019 - whuhzzs.com
… the safety and efficacy of dual vs.triple antithrombotic therapy (DAT vs.TAT) in this
population.Method: This meta analysis … Conclusion: Double antithrombotic therapy may be …
population.Method: This meta analysis … Conclusion: Double antithrombotic therapy may be …
[HTML][HTML] 左心耳封堵术在非瓣膜性心房颤动合并冠心病患者中的安全性及有效性分析
蒋晓敏， 罗杰， 谢渡江， 周陵， 林松… - … 医科大学学报(自然科学版), 2021 - jnmu.njmu.edu.cn
… versus long ⁃term warfarin therapy:the PREVAIL trial[J].J Am … :This study aims to
evaluate the safety and efficiency of the … 使用双联抗血小板治疗(dual antiplatelet therapy,DAPT)或…
evaluate the safety and efficiency of the … 使用双联抗血小板治疗(dual antiplatelet therapy,DAPT)或…
PCI 术后三联与双联抗凝策略疗效比较的Meta 分析.
李姮， 韩聪聪， 任焘君， 徐延敏 - Tianjin Medical Journal, 2016 - search.ebscohost.com
… , clopidogrel) and triple antiplatelet strategy (aspirin, clopidogrel and warfarin) in patients …
(triple antiplatelet treatment 3 330, double antiplatelet treatment 3 753) in this analysis. The …
(triple antiplatelet treatment 3 330, double antiplatelet treatment 3 753) in this analysis. The …
伴and is cosponsored by the University of Tennessee College
III IIIIIIIIIIIIIIIIIIIIIII - search.proquest.com
… activity should not be used by clinicians without the evaluation of … antithrombotic therapy
until the introduction of the low-molecular-weight heparins (LMWHs) in the late 1980s. Warfarin …
until the introduction of the low-molecular-weight heparins (LMWHs) in the late 1980s. Warfarin …
肺癌患者静脉血栓栓塞预防的疗效与安全性的meta 分析
苏俐玫， 毛溪悦， 阳丽梅 - 中国药学(英文版), 2023 - jcps.bjmu.edu.cn
… In conclusion, anticoagulant therapy … have not been systematically assessed. Therefore,
we aimed to conduct a systematic review and meta-analysis to evaluate the efficacy and safety …
we aimed to conduct a systematic review and meta-analysis to evaluate the efficacy and safety …
双联抗血小板治疗在急性卒中的溶栓: 转化研究观点
F Lieschke, Y Zheng, C Foerch… - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
… Thrombolysis in acute stroke under dual antiplatelet therapy: … of focal stroke under dual
antiplatelet therapy (DAPT) to study … Their subgroup analysis revealed, that among all antiplatelets…
antiplatelet therapy (DAPT) to study … Their subgroup analysis revealed, that among all antiplatelets…
利伐沙班联合硫酸氢氯吡格雷在老年急性冠脉综合征合并非瓣膜性心房颤动患者PCI 术后的应用效果和安全性.
钱丹丹， 吴军， 崔杨慧 - Evaluation & Analysis of Drug-Use in …, 2023 - search.ebscohost.com
… efficacy and safety of rivaroxaban combined with clopidogrel bisulfate for dual antithrombotic
therapy ( DAT) in the treatment … given triple antithrombotic therapy (TAT) of warfarin, aspirin …
therapy ( DAT) in the treatment … given triple antithrombotic therapy (TAT) of warfarin, aspirin …
单中心非瓣膜性心房颤动患者抗栓现状分析及建议
谢煌烈， 韩鹏宇， 郑朝阳， 朱伟， 陶文祥， 王恒坤 - 中国全科医学, 2021 - chinagp.net
… CHD prevalence in non-antithrombotic group was lower than that … dual antiplatelet therapy
group,and so did that in warfarin group(P<0.05).CHD prevalence in dual antiplatelet therapy …
group,and so did that in warfarin group(P<0.05).CHD prevalence in dual antiplatelet therapy …